Skip Navigation

European Heart Journal 1996 17(10):1470-1476;
Copyright © 1996 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wallentin, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wallentin, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 The European Society of Cardiology

Low molecular weight heparins: a valuable tool in the treatment of acute coronary syndromes

L. Wallentin

Department of cardiology, University Hospital Uppsala, Sweden

revised 26 March 1996; accepted 28 March 1996.

Professor Lars Wallentin. Department of Cardiology, University Hospital, S-75l 85 Uppsala, Sweden

Abstract

Standard heparin, low molecular weight heparin and aspirin are at present the only antithrombotic agents of proven value in the initial treatment of patients with an acute coronary syndrome. The combined use of aspirin and one of the heparins for at least 6 days should be considered for all such patients. With their high bio availability after subcutaneous injection and prolonged half-life, low molecular weight heparins simplify short-term treatment in the acute phase and enable long-term therapy to be maintained on an outpatient basis without the need for repeated laboratory monitoring of anticoagulant effects. Such long-term therapy would appear to be beneficial, at least in high-risk patients, in the light of increasing evidence that the underlying lesion in acute coronary syndromes resolves over a period of weeks or months.

Key Words: Angina pectoris • aspirin • coagulation • heparin • low molecular weight heparin • myocardial infraction • non-Q wave myocardial infraction • thrombosis • unstable angina pectoris


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Emerg. Med. J.Home page
A Wakai, A Gleeson, and D Winter
Role of fibrin D-dimer testing in emergency medicine
Emerg. Med. J., July 1, 2003; 20(4): 319 - 325.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
L. Wallentin
New trials of LMW heparins -- light and heavy weight as good on short but what about longer distances?
Eur. Heart J., November 1, 1999; 20(21): 1522 - 1524.
[PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.